Enveric Biosciences (ENVB) Gross Margin (2014 - 2020)
Enveric Biosciences (ENVB) recorded Gross Margin of 22.25% in Q3 2020, up 1.49 percentage points from 20.76% a year earlier and up 0.23 percentage points from the prior quarter.
Powered by 
Analysis
Enveric Biosciences (ENVB) Gross Margin (2014 - 2020) Analysis & Trends
On a TTM basis, Enveric Biosciences' Gross Margin came in at 20.66% as of Sep 30, 2020, up 0.42 percentage points year-over-year; for FY2019, it came in at 20.42%, down 0.47 percentage points from FY2018.
- Annual Gross Margin has a four-year change of -13.49 percentage points (FY2015 to FY2019).
- Across earlier years, Gross Margin came in at 20.89% in FY2018 (-0.18 pp), 21.07% in FY2017 (+1.90 pp), 19.17% in FY2016 (-14.74 pp) and 33.91% in FY2015.
- The Q3 2020 figure is the highest quarterly Gross Margin since Q1 2017.
- On a year-over-year basis, Gross Margin rose in five of the last eight quarters, with an average year-over-year change of +0.03 percentage points.
- Peak year-over-year performance for Gross Margin in the last five years was a gain of 8.85 percentage points in Q1 2017, against a drop of 27.21 percentage points in Q4 2016 at the low end.
- Per Business Quant, the preceding three quarters came in at 22.02% (Q2 2020), 19.59% (Q1 2020) and 19.08% (Q4 2019).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 68.19% |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 74.74% |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 73.54% |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 78.02% |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 83.60% |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 72.04% |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 79.76% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 72.78% |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 85.33% |
| 10 | Enveric Biosciences | 5.71 Mn | -15.93 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2020 | 22.25% |
| Jun 30, 2020 | 22.02% |
| Mar 31, 2020 | 19.59% |
| Dec 31, 2019 | 19.08% |
| Sep 30, 2019 | 20.76% |
| Jun 30, 2019 | 21.63% |
| Mar 31, 2019 | 20.03% |
| Dec 31, 2018 | 18.53% |
| Sep 30, 2018 | 22.18% |
| Jun 30, 2018 | 21.57% |
| Mar 31, 2018 | 21.18% |
| Dec 31, 2017 | 17.81% |
| Sep 30, 2017 | 20.46% |
| Jun 30, 2017 | 19.01% |
| Mar 31, 2017 | 26.75% |
| Dec 31, 2016 | 16.69% |
| Sep 30, 2016 | 16.87% |
| Jun 30, 2016 | 22.69% |
| Mar 31, 2016 | 17.90% |
| Dec 31, 2015 | 43.90% |
API Access
Enveric Biosciences Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=ENVB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "ENVB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=ENVB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();